NCT00260143View on ClinicalTrials.gov

Testosterone and Physical Function in HIV+ Men

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
HIV Associate Weight Loss
Interventions
DRUG

Testosterone enanthate

DRUG

Placebo

Trial Locations (1)

90059

Charles R. Drew University, Los Angeles

All Listed Sponsors
collaborator

Charles Drew University of Medicine and Science

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00260143 - Testosterone and Physical Function in HIV+ Men | Biotech Hunter | Biotech Hunter